Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in Global. It is testing osmotic Release Oral System Methylphenidate for ADHD.
In GlobalThis study is completed in the United States. It focuses on ADHD.
Multiple locations, including Little Rock
This study is completed. It focuses on ADHD and currently lists study information in the United States.
In WilmingtonThis study has public registry information. It focuses on ADHD and currently lists study information in the United States.
In New YorkThis study is completed. It focuses on ADHD and currently lists study information in Norway.
In BergenThis study is completed. It focuses on ADHD and currently lists study information in Romania.
In Cluj-Napoca
This study is completed. It focuses on ADHD and currently lists study information in Sweden.
In HalmstadThis study is enrolling by invitation. It focuses on ADHD and currently lists participation information in the United States.
Multiple locations, including San JoseThis study is enrolling by invitation. It focuses on ADHD and currently lists participation information in the United States.
Multiple locations, including MobileThis study is completed. It focuses on ADHD and currently lists study information in the Netherlands.
In The HagueThis study is completed. It focuses on ADHD and currently lists study information in Japan.
In ChibaThis study is completed in the United States. It is testing naltrexone for ADHD.
In Boston